AAPL350.72-2.06 (-0.58%) ▼|ABBV292.37-2.18 (-0.74%) ▼|ABT104.93-2.52 (-2.35%) ▼|ACN240.58-7.12 (-2.87%) ▼|ADBE235.81-10.19 (-4.14%) ▼|AMAT343.11-7.14 (-2.04%) ▼|AMD489.57-14.71 (-2.92%) ▼|AMGN456.58-5.74 (-1.24%) ▼|AMT187.82-2.92 (-1.53%) ▼|AMZN257.34-0.41 (-0.16%) ▼|AVGO338.04+4.64 (+1.39%) ▲|AXP315.54-3.51 (-1.10%) ▼|BA163.68-1.54 (-0.93%) ▼|BAC49.43-0.66 (-1.31%) ▼|BKNG153.93-3.60 (-2.29%) ▼|BLK1,183.91-14.07 (-1.17%) ▼|BMY61.07-1.86 (-2.96%) ▼|BNY149.99-1.71 (-1.12%) ▼|BRK-B589.73-3.12 (-0.53%) ▼|C119.79-1.54 (-1.27%) ▼|CAT567.33-3.16 (-0.55%) ▼|CL99.60-1.39 (-1.38%) ▼|CMCSA25.48-0.13 (-0.49%) ▼|COF186.77-6.45 (-3.34%) ▼|COP139.57-0.95 (-0.68%) ▼|COST1,112.01-1.74 (-0.16%) ▼|CRM195.10-19.74 (-9.19%) ▼|CSCO94.64+0.12 (+0.12%) ▲|CVS85.64-2.95 (-3.33%) ▼|CVX215.75-1.39 (-0.64%) ▼|DE647.43-6.56 (-1.00%) ▼|DHR225.63-4.29 (-1.86%) ▼|DIS116.24-2.47 (-2.08%) ▼|DUK130.11-0.48 (-0.37%) ▼|EMR158.61-2.04 (-1.27%) ▼|FDX319.54-8.11 (-2.48%) ▼|GD355.04-4.65 (-1.29%) ▼|GE325.23+0.05 (+0.02%) ▲|GEV766.52+2.95 (+0.39%) ▲|GILD169.69+2.11 (+1.26%) ▲|GM83.62+0.01 (+0.01%) ▲|GOOG277.21-4.06 (-1.44%) ▼|GOOGL279.93-3.79 (-1.34%) ▼|GS875.54-16.00 (-1.79%) ▼|HD339.24-8.27 (-2.38%) ▼|HON218.95+1.00 (+0.46%) ▲|IBM231.29-11.22 (-4.63%) ▼|INTC53.74-1.71 (-3.08%) ▼|INTU322.33-23.23 (-6.72%) ▼|ISRG431.46-6.29 (-1.44%) ▼|JNJ279.09-3.47 (-1.23%) ▼|JPM329.90-8.31 (-2.46%) ▼|KO99.08-0.41 (-0.41%) ▼|LIN518.20-5.26 (-1.00%) ▼|LLY1,407.20-24.47 (-1.71%) ▼|LMT586.72+1.51 (+0.26%) ▲|LOW221.24-3.70 (-1.64%) ▼|LRCX207.04-3.79 (-1.80%) ▼|MA647.80-13.91 (-2.10%) ▼|MCD275.73+1.06 (+0.39%) ▲|MDLZ66.95-0.60 (-0.88%) ▼|MDT102.59-0.29 (-0.28%) ▼|META620.98-5.43 (-0.87%) ▼|MMM180.22-1.47 (-0.81%) ▼|MO77.88-1.02 (-1.29%) ▼|MRK143.62-0.85 (-0.58%) ▼|MS183.43-2.14 (-1.15%) ▼|MSFT505.48-12.51 (-2.42%) ▼|MU697.98-21.05 (-2.93%) ▼|NEE84.73-0.61 (-0.71%) ▼|NFLX59.60-1.15 (-1.89%) ▼|NKE35.45-2.81 (-7.34%) ▼|NOW92.43-6.94 (-6.98%) ▼|NVDA153.50-2.64 (-1.69%) ▼|ORCL114.66-4.43 (-3.72%) ▼|PEP141.79-4.65 (-3.17%) ▼|PFE28.43-0.43 (-1.49%) ▼|PG171.93-1.09 (-0.63%) ▼|PLTR156.68-3.72 (-2.32%) ▼|PM195.54-0.50 (-0.26%) ▼|QCOM165.37-3.15 (-1.87%) ▼|RTX197.23+2.34 (+1.20%) ▲|SBUX107.41-1.32 (-1.21%) ▼|SCHW91.97-0.98 (-1.05%) ▼|SO93.53-1.11 (-1.17%) ▼|SPG230.82-1.96 (-0.84%) ▼|T22.39+0.03 (+0.13%) ▲|TMO687.97-3.36 (-0.49%) ▼|TMUS169.02-0.99 (-0.58%) ▼|TSLA378.58-1.16 (-0.31%) ▼|TXN293.25-0.96 (-0.33%) ▼|UBER69.02-0.98 (-1.39%) ▼|UNH387.92-24.10 (-5.85%) ▼|UNP298.58-5.13 (-1.69%) ▼|UPS110.61-1.21 (-1.08%) ▼|USB59.33-1.10 (-1.82%) ▼|V418.16-8.30 (-1.95%) ▼|VZ46.18-0.17 (-0.36%) ▼|WFC82.87-1.97 (-2.32%) ▼|WMT127.50-0.91 (-0.71%) ▼|XOM166.68-0.19 (-0.11%) ▼|AAPL350.72-2.06 (-0.58%) ▼|ABBV292.37-2.18 (-0.74%) ▼|ABT104.93-2.52 (-2.35%) ▼|ACN240.58-7.12 (-2.87%) ▼|ADBE235.81-10.19 (-4.14%) ▼|AMAT343.11-7.14 (-2.04%) ▼|AMD489.57-14.71 (-2.92%) ▼|AMGN456.58-5.74 (-1.24%) ▼|AMT187.82-2.92 (-1.53%) ▼|AMZN257.34-0.41 (-0.16%) ▼|AVGO338.04+4.64 (+1.39%) ▲|AXP315.54-3.51 (-1.10%) ▼|BA163.68-1.54 (-0.93%) ▼|BAC49.43-0.66 (-1.31%) ▼|BKNG153.93-3.60 (-2.29%) ▼|BLK1,183.91-14.07 (-1.17%) ▼|BMY61.07-1.86 (-2.96%) ▼|BNY149.99-1.71 (-1.12%) ▼|BRK-B589.73-3.12 (-0.53%) ▼|C119.79-1.54 (-1.27%) ▼|CAT567.33-3.16 (-0.55%) ▼|CL99.60-1.39 (-1.38%) ▼|CMCSA25.48-0.13 (-0.49%) ▼|COF186.77-6.45 (-3.34%) ▼|COP139.57-0.95 (-0.68%) ▼|COST1,112.01-1.74 (-0.16%) ▼|CRM195.10-19.74 (-9.19%) ▼|CSCO94.64+0.12 (+0.12%) ▲|CVS85.64-2.95 (-3.33%) ▼|CVX215.75-1.39 (-0.64%) ▼|DE647.43-6.56 (-1.00%) ▼|DHR225.63-4.29 (-1.86%) ▼|DIS116.24-2.47 (-2.08%) ▼|DUK130.11-0.48 (-0.37%) ▼|EMR158.61-2.04 (-1.27%) ▼|FDX319.54-8.11 (-2.48%) ▼|GD355.04-4.65 (-1.29%) ▼|GE325.23+0.05 (+0.02%) ▲|GEV766.52+2.95 (+0.39%) ▲|GILD169.69+2.11 (+1.26%) ▲|GM83.62+0.01 (+0.01%) ▲|GOOG277.21-4.06 (-1.44%) ▼|GOOGL279.93-3.79 (-1.34%) ▼|GS875.54-16.00 (-1.79%) ▼|HD339.24-8.27 (-2.38%) ▼|HON218.95+1.00 (+0.46%) ▲|IBM231.29-11.22 (-4.63%) ▼|INTC53.74-1.71 (-3.08%) ▼|INTU322.33-23.23 (-6.72%) ▼|ISRG431.46-6.29 (-1.44%) ▼|JNJ279.09-3.47 (-1.23%) ▼|JPM329.90-8.31 (-2.46%) ▼|KO99.08-0.41 (-0.41%) ▼|LIN518.20-5.26 (-1.00%) ▼|LLY1,407.20-24.47 (-1.71%) ▼|LMT586.72+1.51 (+0.26%) ▲|LOW221.24-3.70 (-1.64%) ▼|LRCX207.04-3.79 (-1.80%) ▼|MA647.80-13.91 (-2.10%) ▼|MCD275.73+1.06 (+0.39%) ▲|MDLZ66.95-0.60 (-0.88%) ▼|MDT102.59-0.29 (-0.28%) ▼|META620.98-5.43 (-0.87%) ▼|MMM180.22-1.47 (-0.81%) ▼|MO77.88-1.02 (-1.29%) ▼|MRK143.62-0.85 (-0.58%) ▼|MS183.43-2.14 (-1.15%) ▼|MSFT505.48-12.51 (-2.42%) ▼|MU697.98-21.05 (-2.93%) ▼|NEE84.73-0.61 (-0.71%) ▼|NFLX59.60-1.15 (-1.89%) ▼|NKE35.45-2.81 (-7.34%) ▼|NOW92.43-6.94 (-6.98%) ▼|NVDA153.50-2.64 (-1.69%) ▼|ORCL114.66-4.43 (-3.72%) ▼|PEP141.79-4.65 (-3.17%) ▼|PFE28.43-0.43 (-1.49%) ▼|PG171.93-1.09 (-0.63%) ▼|PLTR156.68-3.72 (-2.32%) ▼|PM195.54-0.50 (-0.26%) ▼|QCOM165.37-3.15 (-1.87%) ▼|RTX197.23+2.34 (+1.20%) ▲|SBUX107.41-1.32 (-1.21%) ▼|SCHW91.97-0.98 (-1.05%) ▼|SO93.53-1.11 (-1.17%) ▼|SPG230.82-1.96 (-0.84%) ▼|T22.39+0.03 (+0.13%) ▲|TMO687.97-3.36 (-0.49%) ▼|TMUS169.02-0.99 (-0.58%) ▼|TSLA378.58-1.16 (-0.31%) ▼|TXN293.25-0.96 (-0.33%) ▼|UBER69.02-0.98 (-1.39%) ▼|UNH387.92-24.10 (-5.85%) ▼|UNP298.58-5.13 (-1.69%) ▼|UPS110.61-1.21 (-1.08%) ▼|USB59.33-1.10 (-1.82%) ▼|V418.16-8.30 (-1.95%) ▼|VZ46.18-0.17 (-0.36%) ▼|WFC82.87-1.97 (-2.32%) ▼|WMT127.50-0.91 (-0.71%) ▼|XOM166.68-0.19 (-0.11%) ▼|
13.9 C
New York
Tuesday, November 17, 2026

Energy

November Journal of Cardiac Failure Focus Issue on Artificial Intelligence: AI Echo Raises HFpEF Detection to 78%

The November Journal of Cardiac Failure focus issue on artificial intelligence in heart failure also features a large language model study of why patients with heart failure go without...

Alpha Aesthetics Partners Launches Practice Aesthetics, a First-of-Its-Kind Clinical Education Platform

BOSTON, Nov. 17, 2026 /PRNewswire/ -- Alpha Aesthetics Partners ("Alpha"), a leading medical aesthetics...

RushDATA™ Enables Wet-Lab Validation of AI-Designed Antibodies Generated by Molence Bio’s Mol-1

CAMBRIDGE, Mass., Nov. 13, 2026 /PRNewswire/ -- Biointron Biological USA Inc. ("Biointron") is pleased...

CIBC Named One of Canada’s Top 100 Employers for 15th Straight Year

TORONTO, Nov. 17, 2026 /CNW/ -- CIBC is pleased to announce its recognition as...

Eminent Gold to Present at Red Cloud’s Fall Mining Showcase 2026

Vancouver, British Columbia--(Newsfile Corp. - October 20, 2026) - Eminent Gold (TSXV: EMNT) (OTCQB: EMGDF), currently drilling and advancing a Nevada gold discovery opportunity...

Xylyx Bio announces FDA Orphan Drug Designation and $2.99M NIH SBIR grant award for its lead organ graft product, Inspirex™ Lung

Inspirex™ Lung is an investigational human whole lung graft being developed to increase the supply of lungs available for transplantationBROOKLYN, N.Y., Oct. 20, 2026...

OREF HOLDS DAY OF GIVING TO FUND RESEARCH ON MSK DISEASES THAT AFFECT MILLIONS

ROSEMONT, Ill., Oct. 20, 2026 /PRNewswire/ -- On October 22, the Orthopaedic Research and Education Foundation (OREF) will hold its second annual Day of...

Insmed Appoints Two New Directors to Its Board

—Paul Hudson, Former CEO of Sanofi and Novartis Pharmaceuticals, and Utpal Koppikar, CFO of Verily Health and Veteran Biopharma Finance Leader, Join as New...

Xinhua Silk Road: Bailong Chuangyuan to showcase star products at SupplySide Global 2026 in Las Vegas

BEIJING, Oct. 20, 2026 /PRNewswire/ -- At the SupplySide Global to be held during October 28-30 in Las Vegas, U.S., Chinese functional ingredient producer Shandong...

Grünenthal advances proprietary Nociceptin Receptor (NOP) Agonist into Phase II trial in acute pain

Potential first-in-class, selective nociceptin receptor (NOP) agonist that aims to provide safe, effective treatment for moderate to severe acute pain.Following successful Phase I results...

Hengrui Pharma Previews ESMO Congress 2026 with 64 Research Findings Across Its Innovative Oncology Portfolio

64 findings accepted, including three Proffered Paper and three Rapid Oral presentations, spanning more than ten oncology and supportive care areas.More than ten studies...

New Innovative Molecular Technology Combination “LAMP + CRISPR” as CE-IVD

A Collaboration Leads to Molecularbiological InnovationMUNICH, Oct. 20, 2026 /CNW/ -- AmplexDiagnostics and Scope Biosciences are proud to introduce a groundbreaking solution in molecular...

SIEW 2026 Brings Together Global Energy Leaders to “Connect Energy Systems, Power Tomorrow”

SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- The 19th Singapore International Energy Week (SIEW) will open on 26 October, bringing together global policymakers, industry leaders and...

SIEW 2026 Brings Together Global Energy Leaders to “Connect Energy Systems, Power Tomorrow”

SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- The 19th Singapore International Energy Week (SIEW) will open on 26 October, bringing together global policymakers, industry leaders and...

Building a Nuclear-Ready Future: Industry Leaders Gather in Singapore to Strengthen Supply Chain Resilience and Capability

SINGAPORE, Oct. 20, 2026 /PRNewswire/ -- As countries across Asia-Pacific explore the role of nuclear energy in meeting future energy and decarbonisation goals, industry...

Sisram Medical Announces NMPA Acceptance of Profhilo Registration Application for Facial Indication

Advancing Commercialization Preparations to Expand Injectables Presence in ChinaHONG KONG, Oct. 19, 2026 /PRNewswire/ -- Sisram Medical Ltd (the "Company" or "Sisram", 1696.HK), a global...

Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity

-     Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first-in-class fixed-dose combinations.-     ASC36o, a once-weekly oral amylin receptor peptide agonist, is...

Ascletis Announces Positive Preclinical Data for the Most Comprehensive Once-Weekly Oral Peptide Pipeline for the Treatment of Obesity

-     Ascletis' industry-leading once-weekly oral peptide pipeline covers all four validated targets, with multiple first-in-class fixed-dose combinations.-     ASC36o, a once-weekly oral amylin receptor peptide agonist, is...

- A word from our sponsors -

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.